Stem Cell Clinical Trials

180 recruitingLast updated: July 25, 2026

There are 180 actively recruiting stem cell clinical trials across 30 countries. Studies span Phase 2, Not Applicable, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Boston, Massachusetts, United States, Beijing, Beijing Municipality, China, Suzhou, Jiangsu, China. Updated daily from ClinicalTrials.gov.


Stem Cell Trials at a Glance

180 actively recruiting trials for stem cell are listed on ClinicalTrialsFinder across 6 cities in 30 countries. The largest study group is Phase 2 with 60 trials, with the heaviest enrollment activity in Boston, Beijing, and Suzhou. Lead sponsors running stem cell studies include The First Affiliated Hospital of Soochow University, Peking University People's Hospital, and Children's Hospital Medical Center, Cincinnati.

Treatments under study

About Stem Cell Clinical Trials

Looking for clinical trials for Stem Cell? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Stem Cell trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Stem Cell clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 180 trials

Recruiting
Not Applicable

HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

SurvivorshipHematopoietic Stem Cell TransplantationCancer Survivorship+1 more
Azienda USL Reggio Emilia - IRCCS40 enrolled1 locationNCT07579065
Recruiting
Phase 3

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

allogeneic stem cell transplantationCardiovascular DiseasesAcute Lung Injury+3 more
National Heart, Lung, and Blood Institute (NHLBI)210 enrolled1 locationNCT07613099
Recruiting
Phase 1Phase 2

Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients

Hematopoietic Stem Cell Transplant (HSCT)Hematological MalignancyGVHD - Graft-Versus-Host Disease
Tata Memorial Centre54 enrolled2 locationsNCT07724873
Recruiting
Phase 2

To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers

Hematological MalignanciesHaploidentical Hematopoietic Stem Cell Transplant
Tata Memorial Centre20 enrolled2 locationsNCT07719946
Recruiting
Phase 2

Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant

Oral MucositisHematopoietic Stem Cell Transplantation (HSCT)Hematological Malignancies+1 more
Tata Memorial Centre17 enrolled1 locationNCT07709195
Recruiting

Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

Hematopoietic Stem Cell TransplantationTissue DonorsCellular Immunotherapy, Adoptive+1 more
National Cancer Institute (NCI)2,000 enrolled1 locationNCT03000244
Recruiting
Phase 2

Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma

Multiple MyelomaPost Stem Cell Transplant
Stanford University20 enrolled1 locationNCT06461988
Recruiting
Not Applicable

Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant

Hematopoietic Stem Cell Transplantation
National Cancer Institute (NCI)222 enrolled2 locationsNCT05605574
Recruiting
Not Applicable

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

Hematopoietic Stem Cell TransplantCAR-T Cell Therapy
Duke University177 enrolled1 locationNCT06575712
Recruiting
Phase 3

Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors

Healthy Hematopoietic Stem Cell DonorHealthy Allogeneic Hematopoietic Stem Cell Donor
First Affiliated Hospital of Zhejiang University560 enrolled8 locationsNCT07692841
Recruiting

Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
National Heart, Lung, and Blood Institute (NHLBI)40 enrolled1 locationNCT06093867
Recruiting
Phase 2

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Hematopoietic Stem Cell TransplantationImmunodeficiency
National Cancer Institute (NCI)54 enrolled1 locationNCT05027945
Recruiting
Not Applicable

Mosaic Trial for Stem Cell Transplant Recipients

Multiple MyelomaLymphomaLeukemia+4 more
Northwestern University356 enrolled3 locationsNCT06960993
Recruiting

CMV-CMI in csCMVi After HSCT

Hematopoietic Stem Cell Transplantation (HSCT)Immune ReconstitutionCytomegalovirus Infections
The First Affiliated Hospital of Soochow University40 enrolled1 locationNCT07688759
Recruiting
Early Phase 1

Secretome Treatment for Facial Rejuvenation

Stem CellFacial AgingRejuvenation+1 more
Acorn Biolabs Inc.24 enrolled1 locationNCT07227883
Recruiting
Phase 2

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

Classic Hodgkin LymphomaAutologous Stem Cell Transplant
Masonic Cancer Center, University of Minnesota28 enrolled1 locationNCT06377540
Recruiting
Phase 2

Venetoclax Combined With Azacitidine for Consolidation Therapy in AML

Acute Myeloid LeukemiaConsolidation TherapyHigh-Risk+2 more
The First Affiliated Hospital of Soochow University216 enrolled1 locationNCT07425782
Recruiting
Phase 2

Ivosidenib as Post-HSCT Maintenance for AML

Acute Myeloid Leukemia (AML)IDH1 MutationHematopoietic Stem Cell Transplant (HSCT)
Massachusetts General Hospital75 enrolled6 locationsNCT06707493
Recruiting

Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors

Stem Cell TransplantationPediatric RelapsedGemcitabine+5 more
M.D. Anderson Cancer Center30 enrolled1 locationNCT07662018
Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Hematopoietic Stem Cell Transplant (HSCT)Thrombotic MicroangiopathiesDiffuse Alveolar Hemorrhage+2 more
Children's Hospital Medical Center, Cincinnati2,000 enrolled9 locationsNCT04098445